← Browse by Condition
Medical Condition

nephrotic syndrome in children

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for nephrotic syndrome in children sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — nephrotic syndrome in children Clinical Trials

How many clinical trials are currently recruiting for nephrotic syndrome in children?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for nephrotic syndrome in children, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for nephrotic syndrome in children?
nephrotic syndrome in children research spans Phase 2 (3 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a nephrotic syndrome in children clinical trial?
Eligibility criteria for nephrotic syndrome in children trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
3
Phase 3
1
Top Sponsors
Mao Jianhua 2 trials
Northwell Health 1 trial
National University Hospital, Singapore 1 trial
Children's Hospital of Chongqing Medical University 1 trial

Recruiting Clinical Trials

NCT05588063
Recruiting

taVNS for FRNS in Children

Enrollment
30 pts
Location
United States
Sponsor
Northwell Health
View Trial →
NCT07091175 Phase 2
Recruiting

Dupilumab Therapy in Nephrotic Syndrome in Children

Enrollment
66 pts
Location
Singapore
Sponsor
National University Hospital, ...
View Trial →
NCT06079788 Phase 3
Recruiting

Study of Adrenocorticotropic Hormone on Children With Frequent Relapse or Steroid-dependent Nephrotic Syndrome: a Prospective, Multicenter, Randomized,Open-label Clinical Trial.

Enrollment
140 pts
Location
China
Sponsor
Mao Jianhua
View Trial →
NCT05843968 Phase 2
Recruiting

Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Nephrotic Syndrome

Enrollment
46 pts
Location
China
Sponsor
Children's Hospital of Chongqi...
View Trial →
NCT07087314 Phase 2
Recruiting

A Study of Anti-CD38 Monoclonal Antibody (SG301) Subcutaneous Injection in Children With Nephrotic Syndrome With Frequent Relapses or Steroid Dependence

Enrollment
30 pts
Location
China
Sponsor
Mao Jianhua
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology